Anneleen Schallier

726 total citations
12 papers, 594 citations indexed

About

Anneleen Schallier is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Anneleen Schallier has authored 12 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Anneleen Schallier's work include Neuroscience and Neuropharmacology Research (8 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Epilepsy research and treatment (2 papers). Anneleen Schallier is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Epilepsy research and treatment (2 papers). Anneleen Schallier collaborates with scholars based in Belgium, Japan and United States. Anneleen Schallier's co-authors include Yvette Michotte, Ann Massie, Ilse Smolders, Katia Vermoesen, Ellen Loyens, Shiro Bannai, Hideyo Sato, Dimitri De Bundel, Ruani Fernando and Joeri Van Liefferinge and has published in prestigious journals such as Journal of Neuroscience, Brain Research and The FASEB Journal.

In The Last Decade

Anneleen Schallier

12 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anneleen Schallier Belgium 11 351 193 148 96 78 12 594
Katia Vermoesen Belgium 12 332 0.9× 168 0.9× 132 0.9× 52 0.5× 63 0.8× 15 573
Joeri Van Liefferinge Belgium 14 279 0.8× 228 1.2× 124 0.8× 69 0.7× 58 0.7× 19 597
Eduard Bentea Belgium 17 298 0.8× 276 1.4× 106 0.7× 140 1.5× 98 1.3× 39 794
Giulia Albertini Belgium 15 242 0.7× 195 1.0× 69 0.5× 112 1.2× 130 1.7× 28 598
Tomoya Kitayama Japan 18 457 1.3× 437 2.3× 68 0.5× 238 2.5× 74 0.9× 46 876
Ellen Loyens Belgium 10 242 0.7× 128 0.7× 81 0.5× 82 0.9× 51 0.7× 10 432
Wencke Armsen Germany 9 753 2.1× 490 2.5× 227 1.5× 165 1.7× 85 1.1× 9 1.0k
Robert A. Waniewski United States 11 510 1.5× 298 1.5× 104 0.7× 147 1.5× 106 1.4× 17 765
Brigitte Pfeiffer Germany 10 293 0.8× 318 1.6× 183 1.2× 125 1.3× 142 1.8× 12 751
Zsolt Jurányi Hungary 13 292 0.8× 238 1.2× 49 0.3× 60 0.6× 135 1.7× 35 787

Countries citing papers authored by Anneleen Schallier

Since Specialization
Citations

This map shows the geographic impact of Anneleen Schallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneleen Schallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneleen Schallier more than expected).

Fields of papers citing papers by Anneleen Schallier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anneleen Schallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneleen Schallier. The network helps show where Anneleen Schallier may publish in the future.

Co-authorship network of co-authors of Anneleen Schallier

This figure shows the co-authorship network connecting the top 25 collaborators of Anneleen Schallier. A scholar is included among the top collaborators of Anneleen Schallier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anneleen Schallier. Anneleen Schallier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schallier, Anneleen, Katia Vermoesen, Ellen Loyens, et al.. (2013). l-Theanine intake increases threshold for limbic seizures but decreases threshold for generalized seizures. Nutritional Neuroscience. 16(2). 78–82. 13 indexed citations
2.
Portelli, Jeanelle, Leen Thielemans, Luc Ver Donck, et al.. (2012). Inactivation of the Constitutively Active Ghrelin Receptor Attenuates Limbic Seizure Activity in Rodents. Neurotherapeutics. 9(3). 658–672. 29 indexed citations
3.
Loyens, Ellen, Katia Vermoesen, Anneleen Schallier, Yvette Michotte, & Ilse Smolders. (2011). Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors. Brain Research. 1436. 43–50. 21 indexed citations
4.
Loyens, Ellen, Anneleen Schallier, Siew Yeen Chai, et al.. (2011). Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures. Seizure. 20(8). 602–605. 9 indexed citations
5.
Bundel, Dimitri De, Anneleen Schallier, Ellen Loyens, et al.. (2011). Loss of System xc−Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility. Journal of Neuroscience. 31(15). 5792–5803. 163 indexed citations
6.
Vermoesen, Katia, Ellen Loyens, Tatiana Afrikanova, et al.. (2011). Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models. Epilepsy & Behavior. 22(3). 450–460. 37 indexed citations
7.
Schallier, Anneleen, Ilse Smolders, Debby Van Dam, et al.. (2011). Region- and Age-Specific Changes in Glutamate Transport in the AβPP23 Mouse Model for Alzheimer's Disease. Journal of Alzheimer s Disease. 24(2). 287–300. 93 indexed citations
8.
Massie, Ann, Anneleen Schallier, Katia Vermoesen, Lut Arckens, & Yvette Michotte. (2010). Biphasic and bilateral changes in striatal VGLUT1 and 2 protein expression in hemi-Parkinson rats. Neurochemistry International. 57(2). 111–118. 23 indexed citations
9.
Massie, Ann, Stéphanie Goursaud, Anneleen Schallier, et al.. (2010). Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochemistry International. 57(5). 572–578. 31 indexed citations
10.
Massie, Ann, Anneleen Schallier, Ruani Fernando, et al.. (2010). Dopaminergic neurons of system x c – ‐deficient mice are highly protected against 6‐hydroxydopamine‐induced toxicity. The FASEB Journal. 25(4). 1359–1369. 109 indexed citations
11.
Schallier, Anneleen, Ann Massie, Ellen Loyens, et al.. (2009). vGLUT2 heterozygous mice show more susceptibility to clonic seizures induced by pentylenetetrazol. Neurochemistry International. 55(1-3). 41–44. 24 indexed citations
12.
Massie, Ann, Anneleen Schallier, Birgit Mertens, et al.. (2008). Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport. 19(16). 1589–1592. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Vermoesen Breakdown of academic impact, for papers by Joeri Van Liefferinge Breakdown of academic impact, for papers by Eduard Bentea Breakdown of academic impact, for papers by Giulia Albertini Breakdown of academic impact, for papers by Tomoya Kitayama Breakdown of academic impact, for papers by Ellen Loyens Breakdown of academic impact, for papers by Wencke Armsen Breakdown of academic impact, for papers by Robert A. Waniewski Breakdown of academic impact, for papers by Brigitte Pfeiffer Breakdown of academic impact, for papers by Zsolt Jurányi
Rankless by CCL
2026